Introduction
Surgical operations for minor gynecological conditions are common and often done in outpatient clinics. Local anesthesia is widely used, sometimes combined with propofol alone, 1 or propofol and remifentanil. 2 The need to improve effectiveness and quality has led to the more extensive use of propofol. Moderate sedation has also been claimed to be an alternative to general anesthesia. 3, 4 American 5 and European guidelines 6 give specified recommendations for the use of propofol by doctors who are not anesthetists. However, the use of propofol increases the risk of over-sedation and cardio respiratory instability. 7 Propofol given by patient-controlled sedation (PCS) may be an alternative for moderate sedation for gynecological procedures outside the anesthetic room. Although PCS has been reported as safe 8, 9 and studies on propofol PCS commonly have used opioid supplements for pain control [10] [11] [12] , the impact of opioids for PCS on safety and ease of treatment has not been sufficiently evaluated. PCS seems to decrease doses of sedatives and analgesics compared to sedation by anesthetists.
Widespread use of PCS demands simplicity and a predictable outcome. Our main objective was to evaluate the safety and ease of treatment by randomized use of propofol or propofol/alfentanil for gynecological outpatient procedures. Primary, we hypothesised that alfentanil would increase the need for specific anesthetic interventions in order to maintain cardio respiratory stability. Secondary, we believed that because of the use of local anesthesia for pain control, alfentanil would not improve conditions for surgery.
Methods
Between January 2009 and January 2010, 155 ASA class I -III patients aged between 28 and 84 years old completed this prospective, controlled, randomized, double-blind study. They were treated for incontinence, anterior or posterior repair, or combinations of reconstructive genital surgery (Table 1) . Exclusion criteria comprised clinical evidence of heart failure, severe pulmonary disease, pregnancy, allergy to propofol or soya beans, or communication problems. The CONSORT flowchart describes the exclusion of patients during the trial (Fig.   1 ). The study took place at a University Hospital Gynecological Outpatient Clinic in an operating theatre, after approval from the local ethics committee, and written consent had been obtained from all patients. All procedures were elective, and done or supervised by consultant gynecologists. A nurse anesthetist was present through the whole study period and responsible for the study protocol, surveillance, the PCS-pump, and the safety of the patients, and a consultant anesthetist was immediately available. All patients were examined and found eligible for outpatient surgery by consultant gynecologists, in some cases after consultation with the anesthetist. Patients' characteristics are shown in Table 1 . Patients were informed about the procedure, the study and concept of PCS by telephone by a nurse and a nurse anesthetist. They were instructed to fast for 6 hours before operation and to take 1000 mg of paracetamol and 50 mg of diclofenac one hour before surgery. On arrival the patients were given an infusion of 25 mg/ml glucose 100 ml/hour. Routine preoperative checks were made according to the WHO recommendations for safe surgery. Health, Dublin, UK) was prepared with prepacked code-labeled syringes that contained 50 ml of propofol (14.2 mg/ml) or propofol + alfentanil (14.2 mg/ml + 0.125 mg/ml). According to a randomization template using blocks of six, patients were numbered consecutively and the syringes were switched between the patients. A nurse not involved in the study or the care for the patients kept the computed code key, and was also responsible for preparing the syringes.
After the study had finished the code was broken.
Data and interventions were recorded at baseline, every fifth minute or when the pre-set safety limits were breached. Detailed data from BIS were collected after procedures.
Pre-set limits for the vital measurements were defined so that specific interventions could be made: 1) respiratory rate less than 8 breaths/minute, patients were encouraged to breathe; 2)
oxygen saturation of less than 90 % was treated with an oxygen flow of 3 L/minute; 3) an obstructed airway was handled with chin lift; 4) > 30 seconds episodes of apnea were handled with ventilation by mask; 5) bradycardia of less than 40 beats/minute were treated with atropine 0.5 mg; 6) systolic blood pressure less than 90 mmHg were treated with ephedrine 5 mg; 7) if conditions for operation were impaired or impossible, patients were encouraged to make multiple pushes on the delivery button to deepen the sedation; and 8) if access continued to be impaired, supplementary doses of propofol 10 -20 mg were given.
Before infiltration of local anesthesia, the patients were instructed to press the dose button several times until they felt sedated, and after that they used the sedation system as they liked. Each dose delivered propofol 4.25 mg, with or without alfentanil 0.0375 mg.
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No lock-out period was used and capacity of the pump restricted the maximum dose count to 5/minute. Doses given and doses not given (patient's demand during period of infusion of doses) were recorded by the pump. Local anesthesia with 1.25 mg/ml bupivacaine 30 -40 ml was used for vaginal reconstructive procedures. To reduce pain over a larger area for incontinence surgery, 5 mg/ml mepivacaine 40 ml including 5 μg/ml epinephrine was diluted with saline 60 ml. At the end of the procedure, the surgeon estimated the adequacy of access and visibility: 1=procedure done with no limitations of view or access; 2=some limitations, but they did not influence quality, or speed, or both; 3=view and access limited to the extent 8 (20) 8 that the quality or speed of the operation, or both, was influenced; and 4=operation not possible. Post-operatively the patients were supervised in the recovery room for at least 90 minutes before they were discharged.
Statistical analysis
To aid the statistical analysis we used Statistica ® version 10 (Stat Soft Inc, Tulsa, USA). The significances of differences in the incidences across groups were assessed using the chi square test. Cardiopulmonary data were compared using Student's t test. Comparative analyses between the time intervals of 1 to 10 minutes and 15 to 30 minutes for the two groups were made using repeated analysis of variance (ANOVA). These intervals were chosen because clear changes in cardiopulmonary signs appeared within the first 10 minutes of sedation.
Probabilities of less than 0.05 were accepted as significant.
Results

Data about the PCS
Patients in the propofol group used the pump more often, as the counts of both delivered and demanded doses were higher ( Table 2 ). The pump was used most often during the first 3 minutes. During the following 12 minutes the curve of delivered doses flattened out, followed by a period of attenuating use. There was no significant difference in the ratio of demanded and delivered doses between the groups. When the ratios were compared for the four different types of procedures, those being treated for incontinence had a higher ratio (p = 0.045); the propofol group had a mean ratio of 1.46 (range 1 -2.56) and the propofol/alfentanil group of 1.26 (range 1 -1.63).
Aspects of safety
Sedation with propofol/alfentanil resulted in significantly decreased oxygen saturation compared with propofol alone during both periods (1-10 and 10-30 minutes; p<0.001 and p=0.002, respectively). Propofol/alfentanil also reduced respiratory rate during the first and second periods, compared with propofol alone (p<0.001 for both periods). There were no differences between the two when the group data were compared without taking account of changes over time (Table 3) . (OAA/S levels 3 to 5). The five heavily sedated patients had to be manually ventilated to treat their apnea and desaturation, in contrast to the patients given propofol alone, all of whom breathed spontaneously. Apnea developed only at the beginning of sedation (1-10 minutes) after a period of multiple dose demands in preparation for infiltration of local anesthesia. In three cases the procedure had not yet been started, and in the two remaining patients the infiltration of local anesthesia had just been completed. These five patients had lower body mass, but did not differ in age or demand:delivery ratio from the rest of the patients in the propofol/alfentanil group. They started breathing within a minute, and two of them continued to use the pump. One patient's bradycardia and low blood pressure was treated with atropine 0.5 mg and ephedrine 5 mg. In the remainder the cardiovascular state was stable.
Data from respiratory surveillance showed that the addition of alfentanil to propofol increased the transcutaneous and end tidal levels of carbon dioxide, and required intervention by the nurse anesthetist. Table 3 shows the differences. All interventions took place within the first 13 minutes of sedation.
Measurements of heart rate and systolic arterial blood pressure show that cardiovascular stability was maintained throughout the period of sedation. From 1004 values of systolic blood pressure that were measured, 15 patients had values between 90 and 100 mmHg, and one a single value less than 90 mmHg. This patient was treated with ephedrine, and with atropine for bradycardia (<40 beats/minute). This was the only case of bradycardia detected.
Details of the procedures
The addition of alfentanil influenced the ease of the operation (p=0.02), although the operation time was unaffected (Table 2 ). For 10 patients the operation was not possible with PCS, and progress was secured with additional doses of propofol given by the nurse anesthetist. For nine of the remaining 155 patients (two in the propofol/afentanil group) who used PCS for the whole procedure, the operation was done with some limitations of both view and access. For one of these 9 patients the quality and the speed of operating were affected.
Six of the 10 patients who were given additional doses of propofol were affected during the first half of the study period. The surgeons' individual estimation of whether they were not able to operate, and whether access was affected, were numerically similar (surgeon A to E
and not possible/with limitation): senior surgeon A -4/3, senior surgeon B -4/3, surgeon C -1/2, surgeon D -1/1, and surgeon E -0/0.
The treatment of incontinence and combined procedures were the most likely to fail, and were also those with more limited surgical access. For the treatment of incontinence, patients were asked to cough or bear down while adjustment was made to the tension cord; one patient did not manage to cooperate and cough.
Discussion
The main result of this investigation is that the addition of alfentanil to propofol as PCS made the treatment easier, and fewer supplementary doses of propofol given by the nurse anesthetist were needed. But alfentanil also contributed to an increased need for attention and intervention from the anesthetic professional to maintain the patient's safety. Interventions and supplementary oxygen were needed significantly more often in the alfentanil/propofol group. In this case our hypothesis was confirmed.
In most of the studies regarding PCS for procedural sedation, either propofol alone or propofol and an opioid have been used. 8 Adding opioids seem to contribute to effectiveness and ease of treatment, with minor or no need for interventions. 15, 16 The use of alfentanil in our study was based on reported respiratory depression with remifentanil, 9 in combination with concurrent local anaesthesia infiltration. Combinations of sedative and opioids for PCS are possibly required for uncomfortable procedures where the painful stimulus is constant. Effective peripheral blocks and sedatives together may present challenging problems, although local anaesthesia together with propofol PCS seems safe. 17, 18 Both fluctuating stimuli, and waning need for sedation together with control of pain, may make the combined use of propofol and opioids difficult, and a rapid reduction in stimuli can easily lead to over-sedation. The propofol/alfentanil regimen that we used impair safety, which also was confirmed for incontinence surgery in which target-controlled infusion of propofol and remifentanil resulted in apneic episodes, reduced respiratory rate, oxygen desaturation, and the need for close monitoring. 2 Our use of the same mixtures for gynecological treatment as for burn care 19 , display problems with generalizability, and to ensure safety, tuning of the PCS system is needed. 8 Usually surveys describe a preset loading dose that is infused before the patient uses the PCS. Loading doses that have been used have been calculated from pharmacokinetic modelling that estimated the effect of concentrations of propofol at the site, 16 from weight, 20 or from undefined preset calculations 10 . We prefer that the patients themselves are responsible for induction, as they get feedback from pressing on the delivery button. Using propofol alone this strategy seems safe, although we could find no supporting evidence for either method. Possibly it may be of advantage to exclude alfentanil from the PCS pump and
give it before start of the procedure, as a titrated reduced single dose, adjusted to age, weight or other variables of importance. But there are also a need for randomized studies of the optimal dose of propofol and its effect on safety and the need for interventions. With no lockout period, propofol doses of 3.33 mg, 21 and 4 mg, 22 has been used, and with a lock-out period of one minute doses of 10 mg, 23 17 mg 24 , and 20 mg 20 . Both strategies reported episodes of hypoxemia and required manipulation of the patients' airway to avoid serious events.
We did not have a learning curve through the survey period or a surgeondependent outcome, and are firmly of the opinion that the difference found in operating conditions was an effect from the actual drugs. One can discuss whether the surgeons after a few months of the study really were blinded to the drugs used, but there were at least no obvious differences in procedural failures between the first and second study periods. Two limitations of this trial are the heterogeneous nature of the patients when it comes to surgical diagnosis and the limited numbers of patients studied. The four different procedures were chosen as they are relatively easy to do with PCS. Posterior repair and combination procedures require longer operating time, and are dependent on the patient being relaxed.
Discomfort in the legs from positioning may lead to movement, usually starting after a period of at least half an hour. All procedures included the initial infiltration of local anesthesia, although it was given differently depending on the operation, and all patients were treated according to the same protocol and the five surgeons had experience of all the different procedures. As far as we know, this is the first study that has examined PCS for outpatient gynaecological treatment, and for that reason we included all categories of procedures done during one year.
In conclusion, PCS using propofol alone seems to be safe for the patient. The addition of an opioid increases the risk for respiratory problems and an anaesthetic specialist must be present to monitor the patient and to deal with this problem if it arises. However, our study also shows that the addition of alfentanil to propofol PCS facilitates surgery.
